🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study to evaluate safety and effectiveness of Ilaris in adult and...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2025-03-29
Trial ID
NCT06838143
Treatments Being Tested
The purpose of this study is to evaluate whether Canakinumab has beneficial...
Status
Completed
Location
University Medical Clinic Aarau
Start Date
2020-10-23
Trial ID
NCT04510493
Treatments Being Tested
This is a multi-center double-blind placebo-controlled study to assess the ...
Status
Completed
Location
Allergie-Centrum-Charité, Charité University
Start Date
2011-07
Trial ID
NCT01390350
Treatments Being Tested
The pilot study evaluates the efficacy and safety of Canakinumab (ILARIS®) ...
Status
Terminated
Location
Department of Ophthalmology, Triemli Hospital Zurich
Start Date
2012-04
Trial ID
NCT01589029
Treatments Being Tested
The primary objective of this randomized trial is to test whether a treatme...
Status
Recruiting
Location
University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism
Start Date
2023-04-17
Trial ID
NCT05401578
Treatments Being Tested
This is an exploratory proof-of-concept study to evaluate the safety and ef...
Status
Completed
Location
Novartis Investigator Site
Start Date
2008-04
Trial ID
NCT00663169
Treatments Being Tested
This is a randomized single-blind comparative parallel group study of the s...
Status
Completed
Location
State budgetary healthcare institution of the city of Moscow "City Clinic No. 2 of the Moscow Health Department"
Start Date
2022-09-06
Trial ID
NCT06481189
Canakinumab is an anti-interleukin 1 beta (IL1β) antibody approved for use ...
Status
Unknown
Location
Children's National Medical Center
Start Date
2019-05-01
Trial ID
NCT03936894
Treatments Being Tested
The primary goal of this clinical trial is to test the hypothesis that the ...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2026-03-24
Trial ID
NCT06691217
Treatments Being Tested
This was a non-interventional, retrospective, cross-sectional, descriptive ...
Status
Completed
Location
Novartis
Start Date
2020-06-24
Trial ID
NCT05964946